Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

Exogenous Induction of Cerebral β-Amyloidogenesis Is Governed by Agent and Host

Melanie Meyer-Luehmann, Janaky Coomaraswamy, Tristan Bolmont, Stephan Kaeser, Claudia Schaefer, Ellen Kilger, Anton Neuenschwander, Dorothee Abramowski, Peter Frey, Anneliese L. Jaton, Jean-Marie Vigouret, Paolo Paganetti, Dominic M. Walsh, Paul M. Mathews, Jorge Ghiso, Matthias Staufenbiel, Lary C. Walker and Mathias Jucker
Science
New Series, Vol. 313, No. 5794 (Sep. 22, 2006), pp. 1781-1784
Stable URL: http://www.jstor.org/stable/20031362
Page Count: 4
  • More info
  • Cite this Item
Preview not available
Preview not available

Abstract

Protein aggregation is an established pathogenic mechanism in Alzheimer's disease, but little is known about the initiation of this process in vivo. Intracerebral injection of dilute, amyloid-β (Aβ)--containing brain extracts from humans with Alzheimer's disease or β-amyloid precursor protein (APP) transgenic mice induced cerebral β-amyloidosis and associated pathology in APP transgenic mice in a time- and concentration-dependent manner. The seeding activity of brain extracts was reduced or abolished by Aβ immunodepletion, protein denaturation, or by Aβ immunization of the host. The phenotype of the exogenously induced amyloidosis depended on both the host and the source of the agent, suggesting the existence of polymorphic Aβ strains with varying biological activities reminiscent of prion strains.

Page Thumbnails

  • Thumbnail: Page 
1781
    1781
  • Thumbnail: Page 
1782
    1782
  • Thumbnail: Page 
1783
    1783
  • Thumbnail: Page 
1784
    1784